{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:00:53Z","timestamp":1790654453868,"version":"4.1.0"},"reference-count":93,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2014.00241","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T15:24:04Z","timestamp":1415114644000},"source":"Crossref","is-referenced-by-count":46,"title":["Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis \u00e2\u20ac\u201c Discovery and Implications"],"prefix":"10.3389","volume":"5","author":[{"given":"Sreenivas","family":"Gannavaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranadhir","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Avishek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angamuthu","family":"Selvapandiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Salotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira L.","family":"Nakhasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,5,23]]},"reference":[{"key":"B1","first-page":"85","article-title":"Recent advances in the diagnosis and treatment of kala-azar","volume":"25","author":"Sundar","year":"2012","journal-title":"Natl Med J India"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2233","DOI":"10.1371\/journal.pntd.0002233","article-title":"Diagnosis of visceral leishmaniasis in Bihar India: comparison of the rK39 rapid diagnostic test on whole blood versus serum","volume":"7","author":"Matlashewski","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.vaccine.2012.11.032","article-title":"The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas","volume":"31","author":"Bacon","year":"2013","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"631460","DOI":"10.1155\/2012\/631460","article-title":"Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites","volume":"2012","author":"Selvapandiyan","year":"2012","journal-title":"J Trop Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"808","DOI":"10.4269\/ajtmh.2010.09-0341","article-title":"Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccine","volume":"82","author":"Kumar","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1371\/journal.pntd.0000943","article-title":"Vaccines for the leishmaniases: proposals for a research agenda","volume":"5","author":"Costa","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants","volume":"367","author":"Agnandji","year":"2012","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of vaccination for seasonal influenza in humans","volume":"12","author":"Nakaya","year":"2011","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1128\/CVI.00143-12","article-title":"Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood","volume":"19","author":"Singh","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4269\/ajtmh.2007.76.909","article-title":"The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village","volume":"76","author":"Bern","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.trstmh.2011.08.005","article-title":"Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes","volume":"105","author":"Das","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S1473-3099(10)70320-0","article-title":"Visceral leishmaniasis: elimination with existing interventions","volume":"11","author":"Matlashewski","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1284","DOI":"10.1371\/journal.pntd.0001284","article-title":"Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study","volume":"5","author":"Ostyn","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4269\/ajtmh.2009.80.566","article-title":"Evaluation of leishmanin skin test in Indian visceral leishmaniasis","volume":"80","author":"Gidwani","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1296","DOI":"10.1371\/journal.pntd.0001296","article-title":"Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial","volume":"5","author":"Gidwani","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12421","article-title":"Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis","author":"Vallur","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1955","DOI":"10.1371\/journal.pntd.0001955","article-title":"Low parasite load estimated by qPCR in a cohort of children living in urban area endemic for visceral leishmaniasis in Brazil","volume":"6","author":"dos Santos Marques","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1086\/498042","article-title":"The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis","volume":"192","author":"Ben Salah","year":"2005","journal-title":"J Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1016\/j.vaccine.2009.05.084","article-title":"Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis","volume":"27","author":"Noazin","year":"2009","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1371\/journal.pone.0000040","article-title":"Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology","volume":"1","author":"Forgber","year":"2006","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1128\/IAI.01205-06","article-title":"Bioinformatic identification of tandem repeat antigens of the Leishmania donovani complex","volume":"75","author":"Goto","year":"2007","journal-title":"Infect Immun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1128\/CVI.05024-11","article-title":"KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis","volume":"18","author":"Goto","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"Stager","year":"2000","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1016\/S0264-410X(01)00023-8","article-title":"Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response","volume":"19","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","article-title":"Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis","volume":"174","author":"Basu","year":"2005","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Infect Immun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.vaccine.2005.11.011","article-title":"Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis","volume":"24","author":"Rafati","year":"2006","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1016\/j.vaccine.2009.02.079","article-title":"Leishmania infantum sterol 24-C-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection","volume":"27","author":"Goto","year":"2009","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1046\/j.1365-2249.1999.00918.x","article-title":"Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis","volume":"116","author":"Kemp","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1286-4579(02)00051-5","article-title":"Characterization of the immune response to Leishmania infantum recombinant antigens","volume":"5","author":"de Carvalho","year":"2003","journal-title":"Microbes Infect"},{"key":"B36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.actatropica.2011.08.007","article-title":"DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis","volume":"120","author":"da Silva","year":"2011","journal-title":"Acta Trop"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1016\/j.vaccine.2007.05.010","article-title":"Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis","volume":"25","author":"Moreno","year":"2007","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/infdis\/jir842","article-title":"Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis","volume":"205","author":"Maroof","year":"2012","journal-title":"J Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0952-7915(02)00009-2","article-title":"Epitope dominance, competition and T cell affinity maturation","volume":"15","author":"Kedl","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"B40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"B41","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1073\/pnas.92.22.10267","article-title":"Development of a safe live Leishmania vaccine line by gene replacement","volume":"92","author":"Titus","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B42","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.4049\/jimmunol.161.12.6794","article-title":"Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response","volume":"161","author":"Alexander","year":"1998","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.0105-2896.2004.00190.x","article-title":"Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?","volume":"201","author":"McMahon-Pratt","year":"2004","journal-title":"Immunol Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00281-012-0350-8","article-title":"Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis","volume":"34","author":"Soong","year":"2012","journal-title":"Semin Immunopathol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4269\/ajtmh.2004.71.297","article-title":"Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta)","volume":"71","author":"Porrozzi","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"B46","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.4049\/jimmunol.150.6.2322","article-title":"Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis","volume":"150","author":"Rachamim","year":"1993","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4269\/ajtmh.2007.76.579","article-title":"Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB\/c mice","volume":"76","author":"Tonui","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.0900276","article-title":"Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis","volume":"183","author":"Selvapandiyan","year":"2009","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.4049\/jimmunol.1202801","article-title":"Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB\/c mice","volume":"190","author":"Dey","year":"2013","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1128\/IAI.68.10.5595-5602.2000","article-title":"Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library","volume":"68","author":"Melby","year":"2000","journal-title":"Infect Immun"},{"key":"B51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1046\/j.1365-3024.1999.00244.x","article-title":"Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection","volume":"21","author":"Rivier","year":"1999","journal-title":"Parasite Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/IAI.70.1.62-68.2002","article-title":"Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination","volume":"70","author":"Papadopoulou","year":"2002","journal-title":"Infect Immun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1046\/j.1365-2958.2001.02286.x","article-title":"Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection","volume":"39","author":"Zhang","year":"2001","journal-title":"Mol Microbiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.4049\/jimmunol.179.5.3161","article-title":"SIR2-deficient Leishmania infantum induces a defined IFN-gamma\/IL-10 pattern that correlates with protection","volume":"179","author":"Silvestre","year":"2007","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1756-3305-4-150","article-title":"Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation","volume":"4","author":"Carrion","year":"2011","journal-title":"Parasit Vectors"},{"key":"B57","doi-asserted-by":"publisher","first-page":"25703","DOI":"10.1074\/jbc.M402794200","article-title":"Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania","volume":"279","author":"Selvapandiyan","year":"2004","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine"},{"key":"B59","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1365-2958.2010.07214.x","article-title":"Characterization of a Leishmania stage-specific mitochondrial membrane protein that enhances the activity of cytochrome c oxidase and its role in virulence","volume":"77","author":"Dey","year":"2010","journal-title":"Mol Microbiol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2958.2012.08183.x","article-title":"Deletion of mitochondrial associated ubiquitin fold modifier protein Ufm1 in Leishmania donovani results in loss of beta-oxidation of fatty acids and blocks cell division in the amastigote stage","volume":"86","author":"Gannavaram","year":"2012","journal-title":"Mol Microbiol"},{"issue":"2","key":"B61","doi-asserted-by":"publisher","first-page":"e2707","DOI":"10.1371\/journal.pntd.0002707","article-title":"Deletion of ubiquitin fold modifier protein Ufm1 processing peptidase Ufsp in L. donovani abolishes Ufm1 processing and alters pathogenesis","volume":"8","author":"Gannavaram","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B62","first-page":"6","article-title":"Live attenuated Leishmania vaccines","author":"TDR News","year":"2005"},{"key":"B63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4614-9108-8_4","article-title":"Current status and future challenges for the development of genetically altered live attenuated Leishmania vaccines","volume-title":"Pathogenesis of Leishmaniasis: New Developments in Research","author":"Dey","year":"2014"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/nm1297-1354","article-title":"Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells","volume":"3","author":"Ram","year":"1997","journal-title":"Nat Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1200\/JCO.2005.05.5335","article-title":"Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer","volume":"24","author":"Nemunaitis","year":"2006","journal-title":"J Clin Oncol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1574-6968.2004.tb09571.x","article-title":"Generation of Leishmania mutants lacking antibiotic resistance genes using a versatile hit-and-run targeting strategy","volume":"235","author":"Denise","year":"2004","journal-title":"FEMS Microbiol Lett"},{"key":"B68","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ijpara.2006.12.021","article-title":"The use of Tn5 transposable elements in a gene trapping strategy for the protozoan Leishmania","volume":"37","author":"Laurentino","year":"2007","journal-title":"Int J Parasitol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.molbiopara.2007.05.007","article-title":"Construction and analysis of Leishmania tarentolae transgenic strains free of selection markers","volume":"155","author":"Mureev","year":"2007","journal-title":"Mol Biochem Parasitol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1128\/IAI.72.6.3622-3627.2004","article-title":"Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies","volume":"72","author":"Sp\u00c3\u00a4th","year":"2004","journal-title":"Infect Immun"},{"key":"B71","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fimmu.2012.00251","article-title":"Immunobiology of visceral leishmaniasis","volume":"3","author":"Kumar","year":"2012","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.clim.2006.01.017","article-title":"Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar","volume":"119","author":"Ansari","year":"2006","journal-title":"Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nylen","year":"2007","journal-title":"J Exp Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/17460913.4.2.241","article-title":"Tracing immunity to human leishmaniasis","volume":"4","author":"Nylen","year":"2009","journal-title":"Future Microbiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMe1213392","article-title":"Malaria vaccine trials \u00e2\u20ac\u201c beyond efficacy end points","volume":"367","author":"Daily","year":"2012","journal-title":"N Engl J Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nbt0596-591","article-title":"Vaccine R&D success rates and development times","volume":"14","author":"Struck","year":"1996","journal-title":"Nat Biotechnol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1232910","DOI":"10.1126\/science.1232910","article-title":"Accelerating next-generation vaccine development for global disease prevention","volume":"340","author":"Koff","year":"2013","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.immuni.2010.10.006","article-title":"Systems vaccinology","volume":"33","author":"Pulendran","year":"2010","journal-title":"Immunity"},{"key":"B82","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1146\/annurev-immunol-030409-101317","article-title":"Systems biology in immunology: a computational modeling perspective","volume":"29","author":"Germain","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.smim.2013.05.003","article-title":"Systems biological approaches to measure and understand vaccine immunity in humans","volume":"25","author":"Li","year":"2013","journal-title":"Semin Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"key":"B85","doi-asserted-by":"crossref","first-page":"185ps8","DOI":"10.1126\/scitranslmed.3005624","article-title":"The gracefully aging immune system","volume":"5","author":"Boraschi","year":"2013","journal-title":"Sci Transl Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"B87","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1073\/pnas.1321060111","article-title":"Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination","volume":"111","author":"Furman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B88","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nmeth.1439","article-title":"Cell type-specific gene expression differences in complex tissues","volume":"7","author":"Shen-Orr","year":"2010","journal-title":"Nat Methods"},{"key":"B89","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.immuni.2010.02.001","article-title":"Integrating genomic signatures for immunologic discovery","volume":"32","author":"Haining","year":"2010","journal-title":"Immunity"},{"key":"B90","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.coi.2012.03.010","article-title":"Identifying gnostic predictors of the vaccine response","volume":"24","author":"Haining","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev-immunol-030409-101221","article-title":"A genomic approach to human autoimmune diseases","volume":"28","author":"Pascual","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e1000719","DOI":"10.1371\/journal.ppat.1000719","article-title":"Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics","volume":"6","author":"Diamond","year":"2010","journal-title":"PLoS Pathog"},{"key":"B93","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nri3109","article-title":"Strategies to discover regulatory circuits of the mammalian immune system","volume":"11","author":"Amit","year":"2011","journal-title":"Nat Rev Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T20:57:14Z","timestamp":1689627434000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2014.00241\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,23]]},"references-count":93,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2014.00241","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,23]]}}}